FARALLON CAPITAL MANAGEMENT LLC - Q2 2017 holdings

$9.63 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 81 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 70.8% .

 Value Shares↓ Weighting
SPY SellSPDR S&P 500 ETF TRput$823,934,000
-13.1%
3,407,500
-15.2%
8.56%
-17.7%
NXPI BuyNXP SEMICONDUCTORS N V$703,216,000
+38.5%
6,425,000
+31.0%
7.30%
+31.1%
TWX BuyTIME WARNER INC$700,862,000
+26.8%
6,980,000
+23.4%
7.28%
+20.1%
AABA NewALTABA INC$677,048,00012,427,457
+100.0%
7.03%
BCR NewBARD C R INC$463,101,0001,465,000
+100.0%
4.81%
MBBYF BuyMOBILEYE N V AMSTELVEEN$370,991,000
+233.8%
5,907,500
+226.4%
3.85%
+216.1%
PLYA BuyPLAYA HOTELS & RESORTS NV$365,753,000
+15.5%
30,606,930
+1.5%
3.80%
+9.3%
Q SellQUINTILES IMS HOLDINGS INC$348,637,000
+1.1%
3,895,383
-9.1%
3.62%
-4.3%
FB SellFACEBOOK INCcl a$348,494,000
-5.0%
2,308,214
-10.6%
3.62%
-10.1%
WAB BuyWABTEC CORP$293,944,000
+19.4%
3,212,507
+1.8%
3.05%
+13.0%
GOOG SellALPHABET INCcap stk cl c$279,126,000
-10.8%
307,160
-18.6%
2.90%
-15.6%
V SellVISA INC$264,882,000
+1.8%
2,824,505
-3.5%
2.75%
-3.6%
DVMT BuyDELL TECHNOLOGIES INC$236,278,000
-0.7%
3,866,440
+4.2%
2.45%
-5.9%
ALR BuyALERE INC$218,327,000
+101.3%
4,350,000
+59.3%
2.27%
+90.5%
HDS BuyHD SUPPLY HLDGS INC$188,379,000
-13.6%
6,150,156
+16.0%
1.96%
-18.2%
MSFT SellMICROSOFT CORP$170,370,000
-5.6%
2,471,640
-9.8%
1.77%
-10.7%
RDUS BuyRADIUS HEALTH INC$166,731,000
+38.4%
3,686,300
+18.3%
1.73%
+31.0%
HLF  HERBALIFE LTD$149,736,000
+22.7%
2,099,2030.0%1.56%
+16.1%
SBAC SellSBA COMMUNICATIONS CORP NEWcl a$143,125,000
-7.6%
1,060,969
-17.6%
1.49%
-12.6%
HUN NewHUNTSMAN CORP$140,053,0005,420,000
+100.0%
1.46%
STZ NewCONSTELLATION BRANDS INCcl a$135,760,000700,771
+100.0%
1.41%
LBTYK BuyLIBERTY GLOBAL PLC$135,725,000
+19.2%
4,352,936
+34.0%
1.41%
+12.9%
 SOLARCITY CORPnote 1.625%11/0$135,696,000
+6.0%
143,097,0000.0%1.41%
+0.4%
LBTYA BuyLIBERTY GLOBAL PLC$135,550,000
+20.1%
4,220,104
+34.1%
1.41%
+13.6%
CMCSA SellCOMCAST CORP NEWcl a$130,350,000
-27.3%
3,349,186
-29.8%
1.35%
-31.2%
FIS SellFIDELITY NATL INFORMATION SV$128,233,000
+3.8%
1,501,559
-3.3%
1.33%
-1.8%
CTXS BuyCITRIX SYS INC$127,859,000
+3.2%
1,606,673
+8.2%
1.33%
-2.3%
INFO SellIHS MARKIT LTD$122,902,000
-23.2%
2,790,700
-26.8%
1.28%
-27.3%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$112,786,000
-36.5%
334,825
-38.3%
1.17%
-39.9%
 HERBALIFE LTDnote 2.000% 8/1$112,725,000
+8.9%
108,177,0000.0%1.17%
+3.1%
TMH  TEAM HEALTH HOLDINGS INC$105,359,000
+3.0%
2,298,9000.0%1.09%
-2.5%
VEON BuyVEON LTDsponsored adr$79,895,000
+87.7%
20,433,518
+95.8%
0.83%
+77.7%
ABBV NewABBVIE INC$60,546,000835,000
+100.0%
0.63%
BIIB NewBIOGEN INC$57,664,000212,500
+100.0%
0.60%
CLVS BuyCLOVIS ONCOLOGY INC$57,114,000
+1021.2%
610,000
+662.5%
0.59%
+958.9%
AGN SellALLERGAN PLC$55,303,000
-64.3%
227,500
-64.9%
0.57%
-66.2%
NORD NewNORD ANGLIA EDUCATION INC$49,995,0001,535,000
+100.0%
0.52%
PTLA BuyPORTOLA PHARMACEUTICALS INC$48,025,000
+218.3%
855,000
+122.1%
0.50%
+200.6%
HUM SellHUMANA INC$42,951,000
+5.0%
178,500
-10.1%
0.45%
-0.7%
VRSK NewVERISK ANALYTICS INC$40,736,000482,827
+100.0%
0.42%
WBMD NewWEBMD HEALTH CORP$39,831,000679,130
+100.0%
0.41%
ANTM NewANTHEM INC$39,507,000210,000
+100.0%
0.41%
IMMU BuyIMMUNOMEDICS INC$37,329,000
+38.9%
4,227,500
+1.7%
0.39%
+31.5%
EXEL SellEXELIXIS INC$37,314,000
-51.0%
1,515,000
-56.9%
0.39%
-53.6%
CAB NewCABELAS INC$35,949,000605,000
+100.0%
0.37%
FGEN BuyFIBROGEN INC$34,626,000
+106.0%
1,072,000
+57.2%
0.36%
+95.7%
SLD  SUTHERLAND ASSET MGMT CORP M$34,515,000
+2.8%
2,324,2360.0%0.36%
-2.7%
FOLD NewAMICUS THERAPEUTICS INC$30,210,0003,000,000
+100.0%
0.31%
TRCO NewTRIBUNE MEDIA COcl a$29,966,000735,000
+100.0%
0.31%
RYAAY BuyRYANAIR HLDGS PLCsponsored adr ne$25,699,000
+68.6%
238,813
+30.0%
0.27%
+59.9%
MON NewMONSANTO CO NEW$25,447,000215,000
+100.0%
0.26%
GNCMA NewGENERAL COMMUNICATION INCcl a$23,412,000638,976
+100.0%
0.24%
GRFS  GRIFOLS S Asp adr rep b nvt$22,818,000
+11.9%
1,079,8740.0%0.24%
+5.8%
AKAOQ BuyACHAOGEN INC$20,611,000
-0.1%
948,500
+16.0%
0.21%
-5.3%
AZN SellASTRAZENECA PLCsponsored adr$19,602,000
-45.4%
575,000
-50.1%
0.20%
-48.2%
PBYI SellPUMA BIOTECHNOLOGY INC$18,616,000
-13.8%
213,000
-63.3%
0.19%
-18.6%
SHPG NewSHIRE PLCsponsored adr$17,932,000108,500
+100.0%
0.19%
NVET  NEXVET BIOPHARMA PUB LTD CO$17,720,000
+72.0%
2,648,6960.0%0.18%
+62.8%
ALNY NewALNYLAM PHARMACEUTICALS INC$15,952,000200,000
+100.0%
0.17%
H SellHYATT HOTELS CORP$14,896,000
-55.1%
265,000
-56.8%
0.16%
-57.4%
PTLA NewPORTOLA PHARMACEUTICALS INCput$14,043,000250,000
+100.0%
0.15%
SVRA NewSAVARA INC$13,083,0002,225,000
+100.0%
0.14%
SellSOLARCITY CORPnote 2.750%11/0$12,487,000
-82.1%
12,500,000
-82.7%
0.13%
-83.0%
RXDX NewIGNYTA INC$11,939,0001,153,500
+100.0%
0.12%
STML SellSTEMLINE THERAPEUTICS INC$10,649,000
+6.7%
1,157,500
-0.9%
0.11%
+0.9%
AKBA NewAKEBIA THERAPEUTICS INC$10,490,000730,000
+100.0%
0.11%
WGL NewWGL HLDGS INC$10,012,000120,000
+100.0%
0.10%
KATE BuyKATE SPADE & CO$9,800,000
+100.9%
530,000
+152.4%
0.10%
+88.9%
TGNA NewTEGNA INC$9,655,000670,000
+100.0%
0.10%
HZNP SellHORIZON PHARMA PLC$8,843,000
-75.0%
745,000
-68.9%
0.09%
-76.3%
SAGE NewSAGE THERAPEUTICS INC$7,964,000100,000
+100.0%
0.08%
CYOU NewCHANGYOU COM LTDads rep cl a$6,233,000160,812
+100.0%
0.06%
AMRN  AMARIN CORP PLCspons adr new$6,025,000
+25.9%
1,495,0000.0%0.06%
+21.2%
PCO  PENDRELL CORPcl a new$5,936,000
+11.2%
821,0610.0%0.06%
+5.1%
BKD NewBROOKDALE SR LIVING INC$4,854,000330,000
+100.0%
0.05%
QCOM NewQUALCOMM INC$4,694,00085,000
+100.0%
0.05%
IMGN NewIMMUNOGEN INC$3,591,000505,000
+100.0%
0.04%
GCVRZ  SANOFIright 12/31/2020$2,595,000
-15.6%
6,827,8050.0%0.03%
-20.6%
ZGNX NewZOGENIX INC$2,538,000175,000
+100.0%
0.03%
SellGNC HLDGS INCnote 1.500% 8/1$1,826,000
-14.4%
2,700,000
-22.9%
0.02%
-17.4%
TOCA NewTOCAGEN INC$1,203,000100,000
+100.0%
0.01%
MITL ExitMITEL NETWORKS CORP$0-386,267
-100.0%
-0.03%
ACRS ExitACLARIS THERAPEUTICS INC$0-106,894
-100.0%
-0.04%
ALR ExitALERE INCcall$0-82,000
-100.0%
-0.04%
LJPC ExitLA JOLLA PHARMACEUTICAL CO$0-257,500
-100.0%
-0.08%
GLPG ExitGALAPAGOS NVspon adr$0-120,000
-100.0%
-0.11%
CLUBQ ExitTOWN SPORTS INTL HLDGS INC$0-4,060,082
-100.0%
-0.16%
BMY ExitBRISTOL MYERS SQUIBB CO$0-442,500
-100.0%
-0.26%
GWPH ExitGW PHARMACEUTICALS PLCads$0-250,000
-100.0%
-0.33%
VAL ExitVALSPAR CORP$0-275,000
-100.0%
-0.34%
HW ExitHEADWATERS INC$0-1,305,000
-100.0%
-0.34%
SWC ExitSTILLWATER MNG CO$0-1,811,382
-100.0%
-0.34%
LOGM ExitLOGMEIN INC$0-405,185
-100.0%
-0.43%
PCLN ExitPRICELINE GRP INC$0-24,571
-100.0%
-0.48%
TWX ExitTIME WARNER INCput$0-570,000
-100.0%
-0.61%
FLT ExitFLEETCOR TECHNOLOGIES INC$0-519,352
-100.0%
-0.86%
SIG ExitSIGNET JEWELERS LIMITED$0-1,824,364
-100.0%
-1.39%
LLY ExitLILLY ELI & CO$0-1,597,500
-100.0%
-1.47%
WWAV ExitWHITEWAVE FOODS CO$0-3,658,102
-100.0%
-2.25%
MJN ExitMEAD JOHNSON NUTRITION CO$0-3,577,500
-100.0%
-3.50%
BEAV ExitB/E AEROSPACE INC$0-5,030,000
-100.0%
-3.54%
YHOO ExitYAHOO INC$0-9,975,000
-100.0%
-5.08%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14
13F-HR/A2024-02-12
SC 13G/A2024-02-01
SC 13G/A2024-01-23

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings